QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
Go back to QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel| Qiagen NV (NYSE: QGEN) | Delayed: 42.49 -0.98 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.47 | 52 Week High | $28.50 | |||
| Open | $42.40 | 52 Week Low | $19.94 | |||
| Day High | $42.74 | P/E | 146.52 | |||
| Day Low | $42.22 | EPS | $0.29 | |||
| Volume | 945,730 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
